Macitentan and Ibu drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Macitentan (macitentan) and Ibu (ibuprofen). Common drug interactions include swelling among females and chills among males.

The phase IV clinical study analyzes what interactions people have when they take Macitentan and Ibu. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Macitentan?

Macitentan has active ingredients of macitentan. eHealthMe is studying from 7,371 Macitentan users. Check the latest studies of Macitentan.

What is Ibu?

Ibu has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 246,529 Ibu users. Check the latest studies of Ibu.



On Apr, 22, 2026

33 people who take Macitentan and Ibu together, and have interactions are studied.

Macitentan and Ibu drug interactions.

What are the common drug interactions of Macitentan and Ibu, by gender? *:

female:

  1. Swelling
  2. Drug ineffective
  3. Acidosis (build-up of carbon dioxide in the blood)
  4. Bronchopulmonary dysplasia (chronic lung disorder in infants - enlargement of an organ or tissue by the proliferation of cells of an abnormal type)
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Heart valve incompetence (heart's valves do not work correctly)
  7. Lethargy (tiredness)
  8. Pallor
  9. Pulmonary hypertensive crisis (increase in blood pressure in the lung artery-crisis)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

male:

  1. Chills (felling of cold)
  2. Diarrhoea
  3. Small intestinal obstruction (blockage in small intestine)
  4. Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
  5. Vomiting
  6. Disease progression
  7. Dizziness
  8. Dyspnoea (difficult or laboured respiration)
  9. Fall
  10. Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Macitentan and Ibu, by age (0-1 to 60+)? *:

0-1:

  1. Upper respiratory tract infection
  2. Acidosis (build-up of carbon dioxide in the blood)
  3. Bronchopulmonary dysplasia (chronic lung disorder in infants - enlargement of an organ or tissue by the proliferation of cells of an abnormal type)
  4. Drug ineffective
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Heart valve incompetence (heart's valves do not work correctly)
  7. Lethargy (tiredness)
  8. Pallor
  9. Pulmonary hypertensive crisis (increase in blood pressure in the lung artery-crisis)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

2-9:

n/a

10-19:

  1. Gingival pain (gum pain)
  2. Haemorrhage (bleeding)
  3. Swelling

20-29:

  1. Hypotension (abnormally low blood pressure)
  2. Syncope (loss of consciousness with an inability to maintain postural tone)

30-39:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Bilirubin conjugated increased
  4. Blood albumin decreased
  5. Blood alkaline phosphatase increased
  6. Blood bilirubin increased
  7. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  8. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  9. Epistaxis (bleed from the nose)
  10. Gamma-glutamyltransferase increased

40-49:

  1. Subdural haematoma (blood collects between the skull and the surface of the brain)

50-59:

  1. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  2. Dyspepsia (indigestion)
  3. Hospitalisation
  4. Oxygen consumption increased
  5. Pulmonary veno-occlusive disease (obstructive disease of the pulmonary veins)
  6. Dyspnoea (difficult or laboured respiration)
  7. Asthma
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Cardiac disorder
  10. Decreased appetite

60+:

  1. Fall
  2. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  3. Blood glucose decreased
  4. Bradycardia (abnormally slow heart action)
  5. Cardiac failure
  6. Haemoglobin decreased
  7. Iron deficiency anaemia
  8. Abdominal pain
  9. Adverse drug reaction
  10. Adverse event

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 17 people, 51.52%
  2. Pulmonary Hypertension (increase in blood pressure in the lung artery): 15 people, 45.45%
  3. Headache (pain in head): 5 people, 15.15%
  4. High Blood Pressure: 3 people, 9.09%
  5. Diarrhea: 3 people, 9.09%
  6. Respiratory Tract Infection: 2 people, 6.06%
  7. Depression: 2 people, 6.06%
  8. Dyspnea (difficult or laboured breathing): 2 people, 6.06%
  9. High Blood Cholesterol: 2 people, 6.06%
  10. Hypokalemia (low potassium): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Macitentan and Ibu?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Macitentan and Ibu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Macitentan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ibu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Macitentan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ibu and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on macitentan and ibuprofen (the active ingredients of Macitentan and Ibu, respectively), and Macitentan and Ibu (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: